BR100 Increased By (0.25%)
BR30 Increased By (1.07%)
KSE100 Increased By (0.41%)
KSE30 Increased By (0.37%)
BECO 5.48 Decreased By ▼ -0.01 (-0.18%)
BML 55.90 Decreased By ▼ -0.86 (-1.52%)
BOP 35.20 Increased By ▲ 0.08 (0.23%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.58 Increased By ▲ 0.07 (0.61%)
FCCL 57.20 Increased By ▲ 0.45 (0.79%)
FCSC 5.18 Increased By ▲ 0.03 (0.58%)
FFL 18.11 Increased By ▲ 0.23 (1.29%)
FNEL 1.27 Increased By ▲ 0.02 (1.6%)
HUMNL 11.20 Increased By ▲ 0.08 (0.72%)
KEL 8.63 Increased By ▲ 0.21 (2.49%)
KOSM 6.63 Increased By ▲ 0.05 (0.76%)
MLCF 105.00 Increased By ▲ 1.70 (1.65%)
NBP 200.45 Increased By ▲ 0.27 (0.13%)
PACE 11.29 No Change ▼ 0.00 (0%)
PAEL 44.42 Increased By ▲ 0.95 (2.19%)
PIAHCLA 28.00 Increased By ▲ 0.51 (1.86%)
PIBTL 18.85 Increased By ▲ 1.15 (6.5%)
PPL 245.61 Increased By ▲ 1.29 (0.53%)
PRL 35.47 Increased By ▲ 0.04 (0.11%)
PTC 65.40 Increased By ▲ 0.05 (0.08%)
SEARL 94.00 Increased By ▲ 0.68 (0.73%)
SSGC 32.47 Decreased By ▼ -0.47 (-1.43%)
TELE 8.90 Decreased By ▼ -0.01 (-0.11%)
THCCL 66.90 Increased By ▲ 0.18 (0.27%)
TPLP 10.87 Increased By ▲ 0.04 (0.37%)
TREET 25.35 Increased By ▲ 0.23 (0.92%)
TRG 64.69 Decreased By ▼ -0.21 (-0.32%)
WAVES 10.91 Decreased By ▼ -0.02 (-0.18%)
WTL 1.26 Increased By ▲ 0.01 (0.8%)
World

EU chief defends later vaccine rollout as 'good decision'

  • France's health authority is due later Tuesday to give its verdict on approval of the AstraZeneca vaccine and who it should be used on.
Published February 2, 2021 Updated February 2, 2021 08:24pm
By

PARIS: The EU commission chief has defended the slower Covid-19 vaccine rollout in the bloc as a "good decision", saying the European Union would not put the safety of citizens at risk, in an interview published Tuesday.

Ursula von der Leyen's comments in Le Monde French daily come after she was criticised over a far slower vaccine rollout than in the UK and also a botched move to halt the exports of the AstraZeneca vaccine.

"Some countries started to vaccinate a little before Europe, it is true," she said, pointing to emergency procedures used for authorisation.

But she added: "The commission and the member states agreed not to compromise on the safety and effectiveness requirements linked to the authorisation of a vaccine."

With some politicians in Britain claiming the quicker vaccine rollout there had vindicated Brexit, France's Europe Minister Clement Beaune told French radio that the British vaccination rollout was taking "a lot of risks".

"I do not think that our fellow citizens would accept that we take all the risks -- contrary to the opinions of our scientists -- for this vaccination campaign", he told France Inter.

The head start in Britain "has nothing to do with Brexit", he added.

French President Emmanuel Macron said in interviews published Friday that AstraZeneca's coronavirus vaccine -- which is set to be the backbone of the British campaign -- appeared not to be effective for people over 65 years of age.

France's health authority is due later Tuesday to give its verdict on approval of the AstraZeneca vaccine and who it should be used on.

Comments

Comments are closed for this article.